Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vaccines

Showing results (371-380 of 10,021) with videos related to

Pageof 1,003
Sort By:
Vaccines|January 21, 2023
Rickettsia Vaccine Candidate pVAX1-OmpB24 Stimulates TCD4+INF-γ+ and TCD8+INF-γ+ Lymphocytes in Autologous Co-Culture of Human CellsKarla Dzul-Rosado, Luis Donis-Maturano, Juan Arias-León, et al.
Vaccines|January 21, 2023
Human Coronavirus Cell Receptors Provide Challenging Therapeutic TargetsGeorgina I López-Cortés, Miryam Palacios-Pérez, Margarita M Hernández-Aguilar, et al.
Vaccines|January 21, 2023
Knowledge, Attitudes, Perceptions, and Acceptance of COVID-19 Vaccination among Pharmacy and Non-Pharmacy StudentsHamid Saeed, Khubaib Ali, Muhammad Nabeel, et al.
Vaccines|January 21, 2023
Consistency of Bacterial Triggers in the Pathogenesis of Hidradenitis SuppurativaElia Rosi, Prisca Guerra, Gianmarco Silvi, et al.
Vaccines|January 21, 2023
Understanding the Barriers and Attitudes toward Influenza Vaccine Uptake in the Adult General Population: A Rapid ReviewVerna L Welch, Tom Metcalf, Richard Macey, et al.
Vaccines|March 1, 2019
Epitope-Specific Serological Assays for RSV: Conformation MattersEmily Phung, Lauren A Chang, Kaitlyn M Morabito, et al.
Vaccines|August 28, 2019
Procurement of Category 2 Vaccines in ChinaJian-Lin Zhuang, Abram L Wagner, Megan Laffoon, et al.
Vaccines|August 11, 2019
A Qualitative Study on Gendered Barriers to Livestock Vaccine Uptake in Kenya and Uganda and Their Implications on Rift Valley Fever ControlEdna Mutua, Nicoline de Haan, Dan Tumusiime, et al.
Vaccines|September 7, 2019
Immunomodulatory Potential of <i>Tinospora cordifolia</i> and CpG ODN (TLR21 Agonist) against the Very Virulent, Infectious Bursal Disease Virus in SPF ChicksSwati Sachan, Kuldeep Dhama, Shyma K Latheef, et al.
Vaccines|September 5, 2019
Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus VaccinePatricia Gogesch, Inessa Penner, Steffi Krauter, et al.
Pageof 1,003

Showing results (371-380 of 10,021) with videos related to

Sort By:
Pageof 1,003
Vaccines|January 21, 2023
Rickettsia Vaccine Candidate pVAX1-OmpB24 Stimulates TCD4+INF-γ+ and TCD8+INF-γ+ Lymphocytes in Autologous Co-Culture of Human CellsKarla Dzul-Rosado, Luis Donis-Maturano, Juan Arias-León, et al.
Vaccines|January 21, 2023
Human Coronavirus Cell Receptors Provide Challenging Therapeutic TargetsGeorgina I López-Cortés, Miryam Palacios-Pérez, Margarita M Hernández-Aguilar, et al.
Vaccines|January 21, 2023
Knowledge, Attitudes, Perceptions, and Acceptance of COVID-19 Vaccination among Pharmacy and Non-Pharmacy StudentsHamid Saeed, Khubaib Ali, Muhammad Nabeel, et al.
Vaccines|January 21, 2023
Consistency of Bacterial Triggers in the Pathogenesis of Hidradenitis SuppurativaElia Rosi, Prisca Guerra, Gianmarco Silvi, et al.
Vaccines|January 21, 2023
Understanding the Barriers and Attitudes toward Influenza Vaccine Uptake in the Adult General Population: A Rapid ReviewVerna L Welch, Tom Metcalf, Richard Macey, et al.
Vaccines|March 1, 2019
Epitope-Specific Serological Assays for RSV: Conformation MattersEmily Phung, Lauren A Chang, Kaitlyn M Morabito, et al.
Vaccines|August 28, 2019
Procurement of Category 2 Vaccines in ChinaJian-Lin Zhuang, Abram L Wagner, Megan Laffoon, et al.
Vaccines|August 11, 2019
A Qualitative Study on Gendered Barriers to Livestock Vaccine Uptake in Kenya and Uganda and Their Implications on Rift Valley Fever ControlEdna Mutua, Nicoline de Haan, Dan Tumusiime, et al.
Vaccines|September 7, 2019
Immunomodulatory Potential of <i>Tinospora cordifolia</i> and CpG ODN (TLR21 Agonist) against the Very Virulent, Infectious Bursal Disease Virus in SPF ChicksSwati Sachan, Kuldeep Dhama, Shyma K Latheef, et al.
Vaccines|September 5, 2019
Production Strategies for Pentamer-Positive Subviral Dense Bodies as a Safe Human Cytomegalovirus VaccinePatricia Gogesch, Inessa Penner, Steffi Krauter, et al.
Pageof 1,003